NCT01198548 High-Dose Cholecalciferol in Treating Patients Receiving Combination Chemotherapy and Bevacizumab as First-Line Therapy For Metastatic Colorectal Cancer Status TERMINATED Phase PHASE2
NCT01197560 Study of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B-Cell Lymphoma (DLBCL) Status COMPLETED Phase PHASE2/PHASE3
NCT01193517 Azacitidine and CAPOX in Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01191697 CAPOX, Bevacizumab and Trastuzumab for Patients With HER2-Positive Metastatic Esophagogastric Cancer Status COMPLETED Phase PHASE2
NCT01183663 Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX) Status COMPLETED Phase PHASE1
NCT01178944 Pralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gastroesophageal Junction Cancer Status COMPLETED Phase PHASE2
NCT01167725 Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer Status TERMINATED Phase PHASE3
NCT01164215 Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination Chemotherapy Status COMPLETED Phase PHASE1
NCT01163396 First-line FOLFOXIRI In Combination With Bevacizumab For Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT01159171 A Study of Avastin (Bevacizumab) and Oxaliplatin Plus Xeloda (Capecitabine) in Patients With Advanced Colorectal Cancer. Status COMPLETED Phase PHASE2
NCT01150045 Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Status COMPLETED Phase PHASE3
NCT01130337 A Study of Capecitabine [Xeloda] in Combination With Trastuzumab [Herceptin] and Oxaliplatine in Patients With Resectable Gastric Cancer Status COMPLETED Phase PHASE2
NCT01121848 Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer Status COMPLETED Phase PHASE3
NCT01099449 Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy Status COMPLETED Phase PHASE3
NCT01097265 Study of Micrometastases in Patients With Stage I or Stage II Localized Colon Cancer That Can Be Removed by Surgery Status UNKNOWN Phase PHASE2/PHASE3
NCT01092481 Study Investigating the Role of Oxaliplatin Duration in Modified FOLFOX-6 or CAPOX Regimen as Adjuvant Colon Cancer Therapy Status UNKNOWN Phase PHASE3
NCT01081262 Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT01077739 A Study of Avastin (Bevacizumab) With XELOX or FOLFOX in Patients With Metastatic Colorectal Cancer and Disease Progression Under First-line FOLFIRI and Avastin Status COMPLETED Phase PHASE2
NCT01064999 A Trial of High Intensity Versus Low Intensity Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Status UNKNOWN Phase PHASE2/PHASE3